Related Experiment Videos
Double blind trial with suloctidil, a new vasoactive agent, in elderly patients with psycho-organic brain syndrome
Acta Clinica Belgica
|January 1, 1977
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Impact of adjuvant radiotherapy and chemotherapy on thymoma.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Role of radiotherapy in the management of brain oligometastases.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
[The morbidity and mortality review meetings in radiotherapy departments: Procedure, implementation and prospects of the "Proust" French national project].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
[Comparison of incident reporting and learning systems for radiation oncology in France and abroad].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients.
Radiation oncology (London, England)·2023
GATA2: a small gene with big impact - a case report and literature review.
Acta clinica Belgica·2026
Global Regulatory Frameworks for Cannabinoids and Cannabis-Based Medicinal Products: A Comprehensive Review of Contemporary Approaches and Challenges.
Current reviews in clinical and experimental pharmacology·2026
Comprehensive evaluation of analytical methods for determination of ansamycins across diverse matrices.
Analytical methods : advancing methods and applications·2026
Comparison of the Genotoxic Potential of Three Microcystin Variants (-LR, -RR, and -LF) by High Content Analysis and Micronucleus Assay in a Human Hepatic Cell Line.
Environmental and molecular mutagenesis·2026
In-depth exploration of sugammadex and novel neuromuscular blockade antagonists: a narrative review.
Frontiers in pharmacology·2026